Matches in Nanopublications for { ?s ?p "[Polymorphisms in VEGFR3 and CYP3A5*1 might be able to define a subset of patients with renal-cell carcinoma with decreased sunitinib response and tolerability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_assertion description "[Polymorphisms in VEGFR3 and CYP3A5*1 might be able to define a subset of patients with renal-cell carcinoma with decreased sunitinib response and tolerability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447835.RAZCHheML2CTiklRsjZX6q6rqFKPkQOGcBsWBjyHTMnj8130_provenance.
- assertion description "[Polymorphisms in VEGFR3 and CYP3A5*1 might be able to define a subset of patients with renal-cell carcinoma with decreased sunitinib response and tolerability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP829302.RAxjDe2FoHPzboQ8KQ1QsbLh-G4i2-Sesy2f4w1pFXONU130_assertion description "[Polymorphisms in VEGFR3 and CYP3A5*1 might be able to define a subset of patients with renal-cell carcinoma with decreased sunitinib response and tolerability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829302.RAxjDe2FoHPzboQ8KQ1QsbLh-G4i2-Sesy2f4w1pFXONU130_provenance.
- NP932455.RAVN7SkOaIOyqvPYXAsxdZ3xNmMRCrifOo6AVggPdiywY130_assertion description "[Polymorphisms in VEGFR3 and CYP3A5*1 might be able to define a subset of patients with renal-cell carcinoma with decreased sunitinib response and tolerability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932455.RAVN7SkOaIOyqvPYXAsxdZ3xNmMRCrifOo6AVggPdiywY130_provenance.
- NP408344.RAh8keF2d-iLEYivs8CdyRyC8EqYPjd795uih_j3mlzEw130_assertion description "[Polymorphisms in VEGFR3 and CYP3A5*1 might be able to define a subset of patients with renal-cell carcinoma with decreased sunitinib response and tolerability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408344.RAh8keF2d-iLEYivs8CdyRyC8EqYPjd795uih_j3mlzEw130_provenance.
- NP343720.RAFwcWmEQhUNsuV7k3HxpcEZ48mdxy64W-6Ch_BDtkWVU130_assertion description "[Polymorphisms in VEGFR3 and CYP3A5*1 might be able to define a subset of patients with renal-cell carcinoma with decreased sunitinib response and tolerability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343720.RAFwcWmEQhUNsuV7k3HxpcEZ48mdxy64W-6Ch_BDtkWVU130_provenance.
- NP932456.RAOCSmEuyrhm5arEBi34KKZnY9kJhoJDHDV39WlWJ-c_I130_assertion description "[Polymorphisms in VEGFR3 and CYP3A5*1 might be able to define a subset of patients with renal-cell carcinoma with decreased sunitinib response and tolerability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932456.RAOCSmEuyrhm5arEBi34KKZnY9kJhoJDHDV39WlWJ-c_I130_provenance.